drugset / Trial / NCT02751359
Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers
Phase 1/2
Completed
18 enrolled
University of California, Los Angeles
INSYS Therapeutics Inc · collab
RandomizedSingle-groupDouble-blindBasic science
Summary
The purpose of this double-blind, placebo-controlled study is to determine the analgesic effects of cannabidiol (CBD), a chemical constituent found in cannabis that does not have intoxicating effects. The analgesic effects of CBD will be assessed using the Cold-Pressor Test (CPT), a laboratory model of pain which has predictive validity for the clinical use of analgesics.
Timeline
- Start
- 2016-07
- Primary completion
- 2017-07
- Completion
- 2020-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cannabidiol | Other / unclassified | 200 mg | Oral |
| Comparator | Cannabidiol | Other / unclassified | 400 mg | Oral |
| Comparator | Cannabidiol | Other / unclassified | 800 mg | Oral |
Indications
No indication recorded.